Analyst Viewpoint
Growth in research & development activities and increase in resistance against the practice of animal testing are primary factors boosting the toxicology testing services market size. The safety quotient (SQ) of a drug, chemical, or foodstuff rises if it is checked for toxicity.
Toxicity testing plays a key role in identification of potential adverse effects of chemicals. Rise in predictive toxicology, which predicts properties correlating to toxicity endpoints, is offering lucrative toxicology testing services industry opportunities to companies operating in this sector.
Ban on animal testing in some of the countries has led to a rise in adoption of alternative methods for toxicology testing. This is also fostering market development. Companies operating in the global toxicology testing services market are providing cutting-edge toxic substance analysis and drug toxicity evaluation techniques to increase their market share.
Toxicology testing constitutes finding out the level at which a substance of interest can adversely affect regular biological functions of organisms. 3D cell culture is looked upon as one of the notable advancements, which facilitates safety testing of compounds in in-vitro environment mirroring host physiology.
Researchers are engaged in development of toxicology testing services based on kinetic tissue culture methods, co-culture systems, and 3D human tissue constructs as replacements to animal testing.
Toxicogenomics-based toxicology testing in preclinical studies include ARE-Nrf2 Luciferase assay, direct peptide reactivity assay, and Human Cell Line Activation Test (h-CLAT).
Toxicology testing also helps safeguard the environment. Specialized toxicology testing for environmental risk assessment helps in determining if concentrations of contaminants in a site’s media are higher enough to cause adverse effects in organisms.
However, complexity in data management and analysis has proved to be a key restraint for the toxicology testing services market revenue, as voluminous data generated with in-vitro toxicology experiments leads to the release of large-scale datasets.
Analysis of this data entails advanced computational tools, which can prove to be costly in terms of maintenance. For instance, a pharma company that conducts toxicity screening for any new drug candidate is likely to generate terabytes of data from several assays, making it difficult for researchers to extract insights efficiently.
Drug toxicity evaluation is vital for the development of new drugs and for the extension of the therapeutic potential of the existing molecule. Toxicity testing of new compounds plays a key role in the drug development process.
Increase in need for detection of toxicity of chemicals or drugs in the initial stages of development has led to a rise in research and development activities. Predictive toxicology implies reliance on structure-activity relationship (SAR) modeling for predicting biological activities in chemical structures.
Computational approaches are proving to be conducive to predictive toxicology. Drug toxicity evaluation implies early recognition of the potentially toxic drug molecules. Rise in research activities in this regard is accelerating the demand for integrated toxicology and safety pharmacology services.
There has been a marked resistance against the practice of animal testing for biomedical research in several countries across the globe.
Growth in awareness regarding animal rights and understanding of ethical dilemmas and limitations related to conventional animal testing methods is a primary factor that is driving the need for alternative approaches toward assessing toxicity and safety of products without dependency on experimentation on animals.
Apart from being cumbersome, animal testing entails safety risks around animals involved. For instance, working with rabbit and rodent models increases the chances of contracting zoonotic diseases.
in 2003, the European Animal Research Association passed the 7th Amendment to EU Directive 76/768/EEC, introducing measured prohibition on testing of animals for cosmetics. In March 2013, 100% ban took effect, thereby rendering it unlawful to sell or market cosmetics within the EU if constituent ingredients or finished product were subject to animal testing.
Poison screening solutions are used to detect inorganic poisons in drink and foodstuff. Manufacturers of these solutions are also striving to eliminate the practice of animal testing.
As per the latest toxicology testing services market analysis, North America accounted for the largest share of the global industry in 2022. The region is home to numerous enterprises that provide toxicology testing services.
The U.S. Government has been enacting strict regulations regarding safety assessment of medical devices and chemicals. This is also augmenting the market dynamics of North America.
Toxicology testing services market scenario in Europe and Asia Pacific is expected to witness linear transition toward safety and cost-effectiveness with respect to chemical toxicity testing and toxic substance analysis during the forecast period.
Government bodies of Europe have floated amendments in regulations relating to assessment of safety of chemical substances. On the other hand, Asia Pacific is projected to record considerable market progress in the near future, as CROs in the region are offering toxicology testing services as per regulatory requirements at cheaper prices as compared to those offered in developed countries.
The toxicology testing services market is fragmented, with presence of several well-established players across the globe. Companies are investing in advanced equipment and state-of-the-art facilities in order to support their analytical and bioanalytical activities.
Companies operating in the global landscape are also collaborating with key players to expand their footprint. In March 2023, Agilent Technologies, Inc. completed the acquisition of e-MSion for integrating the latter’s ExD cell into its portfolio comprising advanced analytical solutions and workflows for biotherapeutic development and characterization.
Laboratory Corporation of America Holdings, Charles River Laboratories, Inc., Eurofins Scientific, Bureau Veritas, Envigo, Evotec AG, Merck KGaA, SGS Group, Pharmaceutical Product Development, LLC, and WuXi AppTech are the leading players that account for large toxicology testing services market share.
These firms have been profiled in the toxicology testing services market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 34.7 Bn |
| Market Forecast (Value) in 2031 | US$ 55.7 Bn |
| Growth Rate (CAGR) | 5.5% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 34.7 Bn in 2022
It is projected to grow at a CAGR of 5.5% from 2023 to 2031
Growth in research & development activities and rise in resistance against practice of using animals for biomedical research
The pharmaceutical & biotechnology segment accounted for the largest share in 2022
North America was the dominant region in 2022
Laboratory Corporation of America Holdings, Charles River Laboratories, Inc., Eurofins Scientific, Bureau Veritas, Envigo, Evotec AG, Merck KGaA, SGS Group, Pharmaceutical Product Development, LLC, and WuXi AppTech
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Toxicology Testing Services Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Toxicology Testing Services Market Analysis and Forecast, 2022–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Types of Toxicology Testing Services Tests
5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
5.4. COVID-19 Pandemic Impact on Industry
6. Toxicology Testing Services Market Analysis and Forecast, by Method
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Method, 2017–2031
6.3.1. In Vivo Method
6.3.2. In Vitro Method
6.3.3. In Silico Method
6.4. Market Attractiveness, by Method
7. Toxicology Testing Services Market Analysis and Forecast, by Type of Industry
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type of Industry, 2017–2031
7.3.1. Pharmaceutical & Biotechnology
7.3.2. Cosmetic
7.3.3. Chemical
7.3.4. Medical Devices
7.3.5. Others (Food, Agricultural, and Environmental)
7.4. Market Attractiveness, by Type of Industry
8. Global Toxicology Testing Services Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Toxicology Testing Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Method, 2017–2031
9.2.1. In Vivo Method
9.2.2. In Vitro Method
9.2.3. In Silico Method
9.3. Market Attractiveness, by Method
9.4. Market Value Forecast, by Type of Industry, 2017–2031
9.4.1. Pharmaceutical & Biotechnology
9.4.2. Cosmetic
9.4.3. Chemical
9.4.4. Medical Devices
9.4.5. Others (Food, Agricultural, and Environmental)
9.5. Market Attractiveness, by Type of Industry
9.6. Market Value Forecast, by Country, 2022–2031
9.6.1. U.S.
9.6.2. Canada
9.7. Market Attractiveness Analysis
9.7.1. By Method
9.7.2. By Type of Industry
9.7.3. By Country
10. Europe Toxicology Testing Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Method, 2017–2031
10.2.1. In Vivo Method
10.2.2. In Vitro Method
10.2.3. In Silico Method
10.3. Market Attractiveness, by Method
10.4. Market Value Forecast, by Type of Industry, 2017–2031
10.4.1. Pharmaceutical & Biotechnology
10.4.2. Cosmetic
10.4.3. Chemical
10.4.4. Medical Devices
10.4.5. Others (Food, Agricultural, and Environmental)
10.5. Market Attractiveness, by Type of Industry
10.6. Market Value Forecast, by Country/Sub-region, 2022–2031
10.6.1. Germany
10.6.2. U.K.
10.6.3. France
10.6.4. Italy
10.6.5. Spain
10.6.6. Rest of Europe
10.7. Market Attractiveness Analysis
10.7.1. By Method
10.7.2. By Type of Industry
10.7.3. By Country/Sub-region
11. Asia Pacific Toxicology Testing Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Method, 2017–2031
11.2.1. In Vivo Method
11.2.2. In Vitro Method
11.2.3. In Silico Method
11.3. Market Attractiveness, by Method
11.4. Market Value Forecast, by Type of Industry, 2017–2031
11.4.1. Pharmaceutical & Biotechnology
11.4.2. Cosmetic
11.4.3. Chemical
11.4.4. Medical Devices
11.4.5. Others (Food, Agricultural, and Environmental)
11.5. Market Attractiveness, by Type of Industry
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. China
11.6.2. Japan
11.6.3. India
11.6.4. Australia & New Zealand
11.6.5. Rest of Asia Pacific
11.7. Market Attractiveness Analysis
11.7.1. By Method
11.7.1.1. By Type of Industry
11.7.1.2. By Country/Sub-region
12. Latin America Toxicology Testing Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Method, 2017–2031
12.2.1. In Vivo Method
12.2.2. In Vitro Method
12.2.3. In Silico Method
12.3. Market Attractiveness, by Method
12.4. Market Value Forecast, by Type of Industry, 2017–2031
12.4.1. Pharmaceutical & Biotechnology
12.4.2. Cosmetic
12.4.3. Chemical
12.4.4. Medical Devices
12.4.5. Others (Food, Agricultural, and Environmental)
12.5. Market Attractiveness, by Type of Industry
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Brazil
12.6.2. Mexico
12.6.3. Rest of Latin America
12.7. Market Attractiveness Analysis
12.7.1. By Method
12.7.1.1. By Type of Industry
12.7.1.2. By Country/Sub-region
13. Middle East & Africa Toxicology Testing Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Method, 2017–2031
13.2.1. In Vivo Method
13.2.2. In Vitro Method
13.2.3. In Silico Method
13.3. Market Attractiveness, by Method
13.4. Market Value Forecast, by Type of Industry, 2017–2031
13.4.1. Pharmaceutical & Biotechnology
13.4.2. Cosmetic
13.4.3. Chemical
13.4.4. Medical Devices
13.4.5. Others (Food, Agricultural, and Environmental)
13.5. Market Attractiveness, by Type of Industry
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. GCC Countries
13.6.2. South Africa
13.6.3. Rest of Middle East & Africa
13.7. Market Attractiveness Analysis
13.7.1. By Method
13.7.2. By Type of Industry
13.7.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Laboratory Corporation of America Holdings
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Method Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Charles River Laboratories, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Method Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Eurofins Scientific
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Method Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Bureau Veritas
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Method Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Envigo
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Method Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Evotec AG
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Method Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Merck KGaA
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Method Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. SGS Group
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Method Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Pharmaceutical Product Development, LLC
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Method Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Wuxi AppTec
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Method Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
List of Tables
Table 1: Global Toxicology Testing Services Market Value (US$ Mn) Forecast, by Method, 2017–2031
Table 2: Global Toxicology Testing Services Market Value (US$ Mn) Forecast, by Type of Industry, 2017–2031
Table 3: Global Toxicology Testing Services Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 4: North America Toxicology Testing Services Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 5: North America Toxicology Testing Services Market Value (US$ Mn) Forecast, by Method, 2017–2031
Table 6: North America Toxicology Testing Services Market Value (US$ Mn) Forecast, by Type of Industry, 2017–2031
Table 7: Europe Toxicology Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 8: Europe Toxicology Testing Services Market Value (US$ Mn) Forecast, by Method, 2017–2031
Table 9: Europe Toxicology Testing Services Market Value (US$ Mn) Forecast, by Type of Industry, 2017–2031
Table 10: Asia Pacific Toxicology Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Toxicology Testing Services Market Value (US$ Mn) Forecast, by Method, 2017–2031
Table 12: Asia Pacific Toxicology Testing Services Market Value (US$ Mn) Forecast, by Type of Industry, 2017–2031
Table 13: Latin America Toxicology Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Toxicology Testing Services Market Value (US$ Mn) Forecast, by Method, 2017–2031:
Table 15: Latin America Toxicology Testing Services Market Value (US$ Mn) Forecast, by Type of Industry, 2017–2031:
Table 16: Middle East & Africa Toxicology Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031:
Table 17: Middle East & Africa Toxicology Testing Services Market Value (US$ Mn) Forecast, by Method, 2017–2031:
Table 18: Middle East & Africa Toxicology Testing Services Market Value (US$ Mn) Forecast, by Type of Industry, 2017–2031
List of Figures
Figure 1: Global Toxicology Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 2: Global Toxicology Testing Services Market Value Share, by Method, 2022
Figure 3: Global Toxicology Testing Services Market Value Share, by Type of Industry, 2022
Figure 4: Global Toxicology Testing Services Market Value Share Analysis, by Method, 2022–2031
Figure 5: Global Toxicology Testing Services Market Attractiveness Analysis, by Method, 2023–2031
Figure 6: Global Toxicology Testing Services Market Value Share Analysis, by Type of Industry, 2022–2031
Figure 7: Global Toxicology Testing Services Market Attractiveness Analysis, by Type of Industry, 2023–2031
Figure 8: Global Toxicology Testing Services Market Value Share Analysis, by Region, 2022–2031
Figure 9: Global Toxicology Testing Services Market Attractiveness Analysis, by Region, 2023–2031
Figure 10: North America Toxicology Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: North America Toxicology Testing Services Market Value Share Analysis, by Country, 2022–2031
Figure 12: North America Toxicology Testing Services Market Attractiveness Analysis, by Country, 2023–2031
Figure 13: North America Toxicology Testing Services Market Value Share Analysis, by Method, 2022–2031
Figure 14: North America Toxicology Testing Services Market Attractiveness Analysis, by Method, 2023–2031
Figure 15: North America Toxicology Testing Services Market Value Share Analysis, by Type of Industry, 2022–2031
Figure 16: North America Toxicology Testing Services Market Attractiveness Analysis, by Type of Industry, 2023–2031
Figure 17: Europe Toxicology Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 18: Europe Toxicology Testing Services Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 19: Europe Toxicology Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 20: Europe Toxicology Testing Services Market Value Share Analysis, by Method, 2022–2031
Figure 21: Europe America Toxicology Testing Services Market Attractiveness Analysis, by Method, 2023–2031
Figure 22: Europe Toxicology Testing Services Market Value Share Analysis, by Type of Industry, 2022–2031
Figure 23: Europe Toxicology Testing Services Market Attractiveness Analysis, by Type of Industry, 2023–2031
Figure 24: Asia Pacific Toxicology Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 25: Asia Pacific Toxicology Testing Services Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 26: Asia Pacific Toxicology Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 27: Asia Pacific Toxicology Testing Services Market Value Share Analysis, by Method, 2022–2031
Figure 28: Asia Pacific America Toxicology Testing Services Market Attractiveness Analysis, by Method, 2023–2031
Figure 29: Asia Pacific Toxicology Testing Services Market Value Share Analysis, by Type of Industry, 2022–2031
Figure 30: Asia Pacific Toxicology Testing Services Market Attractiveness Analysis, by Type of Industry, 2023–2031
Figure 31: Latin America Toxicology Testing Services Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Latin America Toxicology Testing Services Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 33: Latin America Toxicology Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Latin America Toxicology Testing Services Market Value Share Analysis, by Method, 2022–2031
Figure 35: Latin America Toxicology Testing Services Market Attractiveness Analysis, by Method, 2023–2031
Figure 36: Latin America Toxicology Testing Services Market Value Share Analysis, by Type of Industry, 2022–2031
Figure 37: Latin America Toxicology Testing Services Market Attractiveness Analysis, by Type of Industry, 2023–2031
Figure 38: Middle East & Africa Toxicology Testing Services Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Middle East & Africa Toxicology Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 40: Middle East & Africa America Toxicology Testing Services Market Value Share Analysis, by Method, 2023–2031
Figure 41: Middle East & Africa America Toxicology Testing Services Market Attractiveness Analysis, by Method, 2023–2031
Figure 42: Global Toxicology Testing Services Market Share Analysis, by Company (2022)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Toxicology Testing Services Market
*86 figures and 60 tables includes